Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 1,890,922 | 1,618,693 | 1,487,973 | 1,324,803 | 1,172,875 |
| Cost of Goods | 121,544 | 110,188 | 105,386 | 102,526 | 117,418 |
| Gross Profit | 1,769,378 | 1,508,505 | 1,382,587 | 1,222,277 | 1,055,457 |
| Operating Expenses | 1,155,084 | 979,851 | 791,319 | 714,583 | 860,288 |
| Operating Income | 614,838 | 528,842 | 591,654 | 508,220 | 195,587 |
| Interest Expense | 78,500 | 77,756 | 61,942 | 56,917 | 52,713 |
| Other Income | -9,078 | -10,978 | 2,355 | -15,370 | 8,683 |
| Pre-tax Income | 527,260 | 440,108 | 532,067 | 435,933 | 151,557 |
| Income Tax | 80,162 | -47,740 | 135,236 | 106,399 | 94,231 |
| Net Income Continuous | 447,098 | 487,848 | 396,831 | 329,534 | 57,326 |
| Minority Interests | N/A | N/A | N/A | -1 | -1,061 |
| Net Income | $447,098 | $487,848 | $396,831 | $329,535 | $58,387 |
| EPS Basic Total Ops | 7.45 | 8.13 | 6.56 | 5.38 | 0.98 |
| EPS Basic Continuous Ops | 7.45 | 8.13 | 6.56 | 5.38 | 0.96 |
| EPS Diluted Total Ops | 7.30 | 7.96 | 6.41 | 5.23 | 0.93 |
| EPS Diluted Continuous Ops | 7.30 | 7.96 | 6.41 | 5.23 | 0.92 |
| EPS Diluted Before Non-Recurring Items | 12.24 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $875,529 | $724,022 | $727,567 | $639,014 | $342,993 |